Research programme: inflammation therapy - Arena

Drug Profile

Research programme: inflammation therapy - Arena

Alternative Names: 19GJ; Inflammation therapy research programme - Arena

Latest Information Update: 21 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Arena Pharmaceuticals
  • Class Small molecules
  • Mechanism of Action G protein-coupled receptor antagonists; G protein-coupled receptor modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Suspended Asthma; Inflammation; Inflammatory bowel diseases; Rheumatoid arthritis

Most Recent Events

  • 02 Aug 2005 This programme is still in active development - (BIO-2005)
  • 23 Mar 2003 Preclinical trials in Asthma in USA (unspecified route)
  • 23 Mar 2003 Preclinical trials in Inflammatory bowel disease in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top